BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31852924)

  • 1. A novel, sensitive dual-indicator cell line for detection and quantification of inducible, replication-competent latent HIV-1 from reservoir cells.
    Salasc F; Gludish DW; Jarvis I; Boliar S; Wills MR; Russell DG; Lever AML; Mok HP
    Sci Rep; 2019 Dec; 9(1):19325. PubMed ID: 31852924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring the Inducible, Replication-Competent HIV Reservoir Using an Ultra-Sensitive p24 Readout, the Digital ELISA Viral Outgrowth Assay.
    Stuelke EL; James KS; Kirchherr JL; Allard B; Baker C; Kuruc JD; Gay CL; Margolis DM; Archin NM
    Front Immunol; 2020; 11():1971. PubMed ID: 32849659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A highly reproducible quantitative viral outgrowth assay for the measurement of the replication-competent latent HIV-1 reservoir.
    Fun A; Mok HP; Wills MR; Lever AM
    Sci Rep; 2017 Feb; 7():43231. PubMed ID: 28233807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CCR5
    Terahara K; Iwabuchi R; Hosokawa M; Nishikawa Y; Takeyama H; Takahashi Y; Tsunetsugu-Yokota Y
    BMC Res Notes; 2019 Apr; 12(1):242. PubMed ID: 31036079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mouse viral outgrowth assay: avatars for the detection of HIV-1 reservoirs.
    Metcalf Pate KA; Blankson JN
    Retrovirology; 2017 Nov; 14(1):52. PubMed ID: 29157283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.
    Passaes CPB; Bruel T; Decalf J; David A; Angin M; Monceaux V; Muller-Trutwin M; Noel N; Bourdic K; Lambotte O; Albert ML; Duffy D; Schwartz O; Sáez-Cirión A
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved assays to measure and characterize the inducible HIV reservoir.
    Massanella M; Yek C; Lada SM; Nakazawa M; Shefa N; Huang K; Richman DD
    EBioMedicine; 2018 Oct; 36():113-121. PubMed ID: 30316868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased T cell trafficking as adjunct therapy for HIV-1.
    Fryer HR; Wolinsky SM; McLean AR
    PLoS Comput Biol; 2018 Mar; 14(3):e1006028. PubMed ID: 29499057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir.
    Wang Z; Simonetti FR; Siliciano RF; Laird GM
    Retrovirology; 2018 Feb; 15(1):21. PubMed ID: 29433524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.
    Ye C; Wang W; Cheng L; Li G; Wen M; Wang Q; Zhang Q; Li D; Zhou P; Su L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling HIV-1 Latency Using Primary CD4
    Takata H; Kessing C; Sy A; Lima N; Sciumbata J; Mori L; Jones RB; Chomont N; Michael NL; Valente S; Trautmann L
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30918072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a Novel Humanized Mouse Model To Investigate
    Flerin NC; Bardhi A; Zheng JH; Korom M; Folkvord J; Kovacs C; Benko E; Truong R; Mota T; Connick E; Jones RB; Lynch RM; Goldstein H
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cyclin T1 during HIV replication and latency establishment in human memory CD4 T cells.
    Couturier J; Orozco AF; Liu H; Budhiraja S; Siwak EB; Nehete PN; Sastry KJ; Rice AP; Lewis DE
    Virol J; 2019 Feb; 16(1):22. PubMed ID: 30786885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The challenge of viral reservoirs in HIV-1 infection.
    Blankson JN; Persaud D; Siliciano RF
    Annu Rev Med; 2002; 53():557-93. PubMed ID: 11818490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
    Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
    Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No evidence of ongoing evolution in replication competent latent HIV-1 in a patient followed up for two years.
    Mok HP; Norton NJ; Hirst JC; Fun A; Bandara M; Wills MR; Lever AML
    Sci Rep; 2018 Feb; 8(1):2639. PubMed ID: 29422601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane.
    Wang Z; Gurule EE; Brennan TP; Gerold JM; Kwon KJ; Hosmane NN; Kumar MR; Beg SA; Capoferri AA; Ray SC; Ho YC; Hill AL; Siliciano JD; Siliciano RF
    Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2575-E2584. PubMed ID: 29483265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals.
    Siliciano JD; Siliciano RF
    Methods Mol Biol; 2005; 304():3-15. PubMed ID: 16061962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep latency: A new insight into a functional HIV cure.
    Elsheikh MM; Tang Y; Li D; Jiang G
    EBioMedicine; 2019 Jul; 45():624-629. PubMed ID: 31227439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-Laboratory Reproducibility of Inducible HIV-1 Reservoir Quantification by TILDA.
    Lungu C; Procopio FA; Overmars RJ; Beerkens RJJ; Voermans JJC; Rao S; Prins HAB; Rokx C; Pantaleo G; Vijver DAMCV; Mahmoudi T; Boucher CAB; Gruters RA; Kampen JJAV
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32887284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.